Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/springer-journals/barriers-and-facilitators-to-oral-prep-use-among-transgender-women-in-xglkBetgBA
References (47)
-
D. Glidden, K. Amico, A. Liu, S. Hosek, P. Anderson, S. Buchbinder, V. McMahan, K. Mayer, Burns David, M. Schechter, B. Grinsztejn, J. Guanira, R. Grant (2016)
Symptoms, Side Effects and Adherence in the iPrEx Open-Label Extension.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 62 9
-
J. Ramirez-Valles, Y. Molina, Jessica Dirkes (2013)
Stigma towards PLWHA: the role of internalized homosexual stigma in Latino gay/bisexual male and transgender communities.AIDS education and prevention : official publication of the International Society for AIDS Education, 25 3
-
J. Molina, C. Capitant, B. Spire, G. Pialoux, L. Cotte, I. Charreau, C. Tremblay, J. Gall, E. Cua, A. Pasquet, F. Raffi, C. Pintado, C. Chidiac, J. Chas, P. Charbonneau, C. Delaugerre, M. Suzan-Monti, B. Loze, J. Fonsart, G. Peytavin, A. Chéret, J. Timsit, G. Girard, N. Lorente, M. Préau, J. Rooney, M. Wainberg, D. Thompson, W. Rozenbaum, V. Doré, L. Marchand, M. Simon, N. Etien, J. Aboulker, L. Meyer, J. Delfraissy (2015)
On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection.The New England journal of medicine, 373 23
-
J. Trussell, J. Trussell, L. Wynn (2008)
Reducing unintended pregnancy in the United States.Contraception, 77 1
-
(2015)
Northwestern receives $17 million grant for HIV prevention research: Northwestern Medicine: Feinberg School of Medicine -
Kathrine Meyers, S. Golub (2015)
Planning ahead for implementation of long-acting HIV prevention: challenges and opportunitiesCurrent Opinion in HIV and AIDS, 10
-
J. Sevelius (2012)
Gender Affirmation: A Framework for Conceptualizing Risk Behavior Among Transgender Women of ColorSex Roles, 68
-
Nadia Dowshen, Susan Lee, Marné Castillo, Linda Hawkins, F. Barg (2016)
Barriers and Facilitators to HIV Prevention, Testing, and Treatment among Young Transgender WomenJournal of Adolescent Health, 58
-
E. Pfau (1980)
[Department of Public Health and health care?].ZFA. Zeitschrift fur Allgemeinmedizin, 56 33
-
E. Elst, J. Mbogua, D. Operario, G. Mutua, C. Kuo, P. Mugo, Jennifer Kanungi, Sagri Singh, J. Haberer, F. Priddy, E. Sanders (2013)
High Acceptability of HIV Pre-exposure Prophylaxis but Challenges in Adherence and Use: Qualitative Insights from a Phase I Trial of Intermittent and Daily PrEP in At-Risk Populations in KenyaAIDS and Behavior, 17
-
R. Brooks, R. Kaplan, E. Lieber, R. Landovitz, Sung-Jae Lee, A. Leibowitz (2011)
Motivators, concerns, and barriers to adoption of preexposure prophylaxis for HIV prevention among gay and bisexual men in HIV-serodiscordant male relationshipsAIDS Care, 23
-
(2017)
City Department of Health and Mental Hygiene: prevent HIV and other STIs -
M. Deutsch, D. Glidden, J. Sevelius, J. Keatley, V. McMahan, J. Guanira, E. Kallás, S. Chariyalertsak, R. Grant (2015)
HIV pre-exposure prophylaxis in transgender women: A subgroup analysis of the iPrEx trialThe lancet. HIV, 2
-
J. Stockman (2012)
Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with MenYearbook of Pediatrics, 2012
-
Judith Green, N. Thorogood (2009)
Qualitative Methods for Health Research. (2nd edition) -
J. Trussell, L. Wynn (2008)
Editorial : reducing unintended pregnancy in the United States (Contraception) -
S. Calabrese, K. Underhill (2015)
How Stigma Surrounding the Use of HIV Preexposure Prophylaxis Undermines Prevention and Pleasure: A Call to Destigmatize "Truvada Whores".American journal of public health, 105 10
-
S. Baral, T. Poteat, S. Strömdahl, A. Wirtz, T. Guadamuz, C. Beyrer (2013)
Worldwide burden of HIV in transgender women: a systematic review and meta-analysis.The Lancet. Infectious diseases, 13 3
-
Gabriel Galindo, Ja’nina Walker, Patrick Hazelton, T. Lane, Wayne Steward, S. Morin, Emily Arnold (2012)
Community member perspectives from transgender women and men who have sex with men on pre-exposure prophylaxis as an HIV prevention strategy: implications for implementationImplementation Science : IS, 7
-
M. Thigpen, P. Kebaabetswe, L. Paxton, Dawn Smith, C. Rose, Tebogo Segolodi, Faith Henderson, S. Pathak, F. Soud, K. Chillag, Rodreck Mutanhaurwa, Lovemore Chirwa, M. Kasonde, Daniel Abebe, Evans Buliva, R. Gvetadze, Sandra Johnson, T. Sukalac, Vasavi Thomas, C. Hart, Jeffrey Johnson, C. Malotte, C. Hendrix, J. Brooks (2012)
Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana.The New England journal of medicine, 367 5
-
L. Damme, A. Corneli, K. Ahmed, K. Agot, Johann Lombaard, S. Kapiga, M. Malahleha, Fredrick Owino, R. Manongi, Jacob Onyango, Lucky Temu, Modie Monedi, Paul Mak'Oketch, M. Makanda, Ilse Reblin, Shumani Makatu, L. Saylor, Haddie Kiernan, Stella Kirkendale, C. Wong, R. Grant, A. Kashuba, K. Nanda, Justin Mandala, K. Fransen, J. Deese, T. Crucitti, T. Mastro, Douglas Taylor (2012)
Preexposure prophylaxis for HIV infection among African women.The New England journal of medicine, 367 5
-
Daniel Escudero, T. Kerr, D. Operario, M. Socías, O. Sued, B. Marshall (2015)
Inclusion of trans women in pre-exposure prophylaxis trials: a reviewAIDS Care, 27
-
J. Sevelius, Enzo Patouhas, J. Keatley, Mallory Johnson (2014)
Barriers and Facilitators to Engagement and Retention in Care among Transgender Women Living with Human Immunodeficiency VirusAnnals of Behavioral Medicine, 47
-
J. Saldaña (2009)
The Coding Manual for Qualitative Researchers -
(2012)
FDA approves first drug for reducing the risk of sexually acquired HIV infection -
(2017)
City Department of Health and Mental Hygiene: be sure, play sure, stay sure -
C. Trezza, S. Ford, W. Spreen, Rennan Pan, S. Piscitelli (2015)
Formulation and pharmacology of long-acting cabotegravirCurrent Opinion in HIV and AIDS, 10
-
I. McGowan, R. Cranston, K. Mayer, I. Febo, K. Duffill, A. Siegel, J. Engstrom, A. Nikiforov, S. Park, R. Brand, Cindy Jacobson, Rebecca Giguere, C. Dolezal, T. Frasca, C. Leu, J. Schwartz, A. Carballo-Diéguez (2016)
Project Gel a Randomized Rectal Microbicide Safety and Acceptability Study in Young Men and Transgender WomenPLoS ONE, 11
-
M. Andrasik, R. Yoon, Jessica Mooney, Gail Broder, Marcus Bolton, Teress Votto, Annet Davis-Vogel, Hvtn Team, Niaid Network (2014)
Exploring Barriers and Facilitators to Participation of Male-to-Female Transgender Persons in Preventive HIV Vaccine Clinical TrialsPrevention Science, 15
-
J. Safer, E. Coleman, J. Feldman, R. Garofalo, W. Hembree, A. Radix, J. Sevelius (2016)
Barriers to healthcare for transgender individualsCurrent Opinion in Endocrinology & Diabetes and Obesity, 23
-
J. Schulden, Binwei Song, Alex Barros, Azul Mares-DelGrasso, Charles Martin, Ramon Ramirez, L. Smith, D. Wheeler, A. Oster, P. Sullivan, J. Heffelfinger (2008)
Rapid HIV Testing in Transgender Communities by Community-Based Organizations in Three CitiesPublic Health Reports, 123
-
Nelson Sánchez, J. Sánchez, A. Danoff (2009)
Health care utilization, barriers to care, and hormone usage among male-to-female transgender persons in New York City.American journal of public health, 99 4
-
J. Sevelius, J. Keatley, Nikki Calma, Emily Arnold (2016)
‘I am not a man’: Trans-specific barriers and facilitators to PrEP acceptability among transgender womenGlobal Public Health, 11
-
M. Markowitz, Kathrine Meyers (2015)
Extending access with long-acting antiretroviral therapy: the next advance in HIV-1 therapeutics and prevention.Current opinion in HIV and AIDS, 10 4
-
J. Sevelius, M. Deutsch, R. Grant (2016)
The future of PrEP among transgender women: the critical role of gender affirmation in research and clinical practicesJournal of the International AIDS Society, 19
-
Sarah Wood, Susan Lee, F. Barg, Marné Castillo, Nadia Dowshen (2017)
Young Transgender Women's Attitudes Toward HIV Pre-exposure Prophylaxis.The Journal of adolescent health : official publication of the Society for Adolescent Medicine, 60 5
-
Kasey Claborn, Ellen Meier, M. Miller, T. Leffingwell (2015)
A systematic review of treatment fatigue among HIV-infected patients prescribed antiretroviral therapyPsychology, Health & Medicine, 20
-
David Thomas (2006)
A General Inductive Approach for Analyzing Qualitative Evaluation DataAmerican Journal of Evaluation, 27
-
(2012)
and Drug Administration -
J. Baeten, D. Donnell, P. Ndase, N. Mugo, J. Campbell, Jonathan Wangisi, J. Tappero, E. Bukusi, C. Cohen, E. Katabira, A. Ronald, Elioda Tumwesigye, E. Were, K. Fife, J. Kiarie, C. Farquhar, G. John-Stewart, Aloysious Kakia, J. Odoyo, A. Mucunguzi, E. Nakku-Joloba, R. Twesigye, K. Ngure, Cosmas Apaka, H. Tamooh, Fridah Gabona, A. Mujugira, D. Panteleeff, Katherine Thomas, L. Kidoguchi, M. Krows, Jennifer Revall, Susan Morrison, Harald Haugen, Mira Emmanuel-ogier, Lisa Ondrejcek, R. Coombs, L. Frenkel, C. Hendrix, Namandjé Bumpus, D. Bangsberg, J. Haberer, W. Stevens, J. Lingappa, C. Celum (2012)
Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.The New England journal of medicine, 367 5
-
K. Choopanya, Michael Martin, P. Suntharasamai, Udomsak Sangkum, P. Mock, M. Leethochawalit, Sithisat Chiamwongpaet, Praphan Kitisin, Pitinan Natrujirote, Somyot Kittimunkong, R. Chuachoowong, R. Gvetadze, J. Mcnicholl, L. Paxton, M. Curlin, C. Hendrix, S. Vanichseni (2013)
Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trialThe Lancet, 381
-
E. Dolgin (2014)
Long-acting HIV drugs advanced to overcome adherence challengeNature Medicine, 20
-
Micaela O’neil-Callahan, J. Peipert, Qiuhong Zhao, T. Madden, G. Secura (2013)
Twenty-Four–Month Continuation of Reversible ContraceptionObstetrics & Gynecology, 122
-
S. Golub, K. Gamarel, H. Rendina, Anthony Surace, C. Leluțiu-Weinberger (2013)
From efficacy to effectiveness: facilitators and barriers to PrEP acceptability and motivations for adherence among MSM and transgender women in New York City.AIDS patient care and STDs, 27 4
-
L. Kuhns, S. Reisner, M. Mimiaga, Travis Gayles, Michael Shelendich, R. Garofalo (2016)
Correlates of PrEP Indication in a Multi-Site Cohort of Young HIV-Uninfected Transgender WomenAIDS and Behavior, 20
-
T. Poteat, A. Wirtz, A. Radix, A. Bórquez, A. Silva-Santisteban, M. Deutsch, S. Khan, S. Winter, D. Operario (2015)
HIV risk and preventive interventions in transgender women sex workersThe Lancet, 385
-
RM Grant, JR Lama, PL Anderson, V McMahan, AY Liu, L Vargas (2010)
Preexposure chemoprophylaxis for HIV prevention in men who have sex with menN Engl J Med, 363
- Publisher
- Springer Journals
- Copyright
- Copyright © 2018 by Springer Science+Business Media, LLC, part of Springer Nature
- Subject
- Medicine & Public Health; Public Health; Health Psychology; Infectious Diseases
- ISSN
- 1090-7165
- eISSN
- 1573-3254
- DOI
- 10.1007/s10461-018-2102-9
- pmid
- 29589137
- Publisher site
- See Article on Publisher Site
Abstract
Transgender women may face a disparate risk for HIV/AIDS compared to other groups. In 2012, Truvada was approved for daily use as HIV pre-exposure prophylaxis (PrEP). However, there is a dearth of research about barriers and facilitators to PrEP in transgender women. This paper will shed light on transgender women living in New York City’s perceived and actual challenges to using PrEP and potential strategies to overcome them. After completing an initial screening process, four 90-min focus groups were completed with n = 18 transgender women. Participants were asked what they like and dislike about PrEP. Participants identified the following barriers: uncomfortable side effects, difficulty taking pills, stigma, exclusion of transgender women in advertising, and lack of research on transgender women and PrEP. Facilitators included: reducing pill size, increasing the types of available HIV prevention products, and conducting scientific studies to evaluate PrEP in transgender women.
Journal
AIDS and Behavior – Springer Journals
Published: Mar 27, 2018